Next Article in Journal
A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
Next Article in Special Issue
Pediatric Suprasellar Germ Cell Tumors: A Clinical and Radiographic Review of Solitary vs. Bifocal Tumors and Its Therapeutic Implications
Previous Article in Journal
Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
Previous Article in Special Issue
Nuclear Receptor Binding Protein 2 Is Downregulated in Medulloblastoma, and Reduces Tumor Cell Survival upon Overexpression

Modern Radiotherapy for Pediatric Brain Tumors

Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
Author to whom correspondence should be addressed.
Cancers 2020, 12(6), 1533;
Received: 30 April 2020 / Revised: 5 June 2020 / Accepted: 6 June 2020 / Published: 11 June 2020
(This article belongs to the Special Issue Pediatric Brain Tumor)
Cancer is a leading cause of death in children with tumors of the central nervous system, the most commonly encountered solid malignancies in this population. Radiotherapy (RT) is an integral part of managing brain tumors, with excellent long-term survival overall. The tumor histology will dictate the volume of tissue requiring treatment and the dose. However, radiation in developing children can yield functional deficits and/or cosmetic defects and carries a risk of second tumors. In particular, children receiving RT are at risk for neurocognitive effects, neuroendocrine dysfunction, hearing loss, vascular anomalies and events, and psychosocial dysfunction. The risk of these late effects is directly correlated with the volume of tissue irradiated and dose delivered and is inversely correlated with age. To limit the risk of developing these late effects, improved conformity of radiation to the target volume has come from adopting a volumetric planning process. Radiation beam characteristics have also evolved to achieve this end, as exemplified through development of intensity modulated photons and the use of protons. Understanding dose limits of critical at-risk structures for different RT modalities is evolving. In this review, we discuss the physical basis of the most common RT modalities used to treat pediatric brain tumors (intensity modulated radiation therapy and proton therapy), the RT planning process, survival outcomes for several common pediatric malignant brain tumor histologies, RT-associated toxicities, and steps taken to mitigate the risk of acute and late effects from treatment. View Full-Text
Keywords: pediatric brain tumors; childhood; radiation; radiotherapy; treatment planning; proton; IMRT; survival; toxicity; late effects pediatric brain tumors; childhood; radiation; radiotherapy; treatment planning; proton; IMRT; survival; toxicity; late effects
Show Figures

Figure 1

MDPI and ACS Style

DeNunzio, N.J.; Yock, T.I. Modern Radiotherapy for Pediatric Brain Tumors. Cancers 2020, 12, 1533.

AMA Style

DeNunzio NJ, Yock TI. Modern Radiotherapy for Pediatric Brain Tumors. Cancers. 2020; 12(6):1533.

Chicago/Turabian Style

DeNunzio, Nicholas J.; Yock, Torunn I. 2020. "Modern Radiotherapy for Pediatric Brain Tumors" Cancers 12, no. 6: 1533.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop